Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 31;9(1):8132.
doi: 10.1038/s41598-019-44609-1.

Factors influencing glycaemic stability after neonatal hypoglycaemia and relationship to neurodevelopmental outcome

Affiliations

Factors influencing glycaemic stability after neonatal hypoglycaemia and relationship to neurodevelopmental outcome

Nataliia Burakevych et al. Sci Rep. .

Abstract

Higher and unstable glucose concentrations in the first 48 hours in neonates at risk of hypoglycaemia have been associated with neurosensory impairment. It is unclear what defines and contributes to instability. This was a prospective study of term and late preterm babies (N = 139) born at risk of neonatal hypoglycaemia who had interstitial glucose (IG) monitoring and ≥1 hypoglycaemic episode <48 hours after birth (blood glucose concentration <2.6 mmol/l [<47 mg/dl]). For 6-hour epochs after each hypoglycaemic episode, masked IG parameters (time to reach maximum IG concentration [hours]; range, average, maximum and minimum IG concentrations; proportion of IG measurements outside the central band of 3-4 mmol/l [54-72 md/dl]; and total duration [hours] of IG concentrations <2.6 mmol/l) were analysed in tertiles and related to: (i) glycaemic instability in the first 48 hours (defined as the proportion of blood glucose concentrations outside the central band in the first 48 hours); (ii) risk factors and treatment for each episode; and (iii) risk of neurosensory impairment at 4.5 years, or at 2 years if a child was not seen at 4.5 years. Glycaemic instability in the first 48 hours was related to IG instability after hypoglycaemia. Risk factors for hypoglycaemia were not related to IG parameters. Treatment with intravenous dextrose was associated with higher IG maximum and range, and lower minimum compared to treatment with dextrose gel plus breast milk, breast milk alone or formula alone. The risk of neurosensory impairment was increased with both shorter and longer time to reach maximum epoch IG (P = 0.04; lower tertile [0.4-2.2 hours] vs middle [2.3-4.2 hours] OR 3.10 [95% CI 1.03; 9.38]; higher tertile [4.3-6.0 hours] vs middle OR 3.07; [95% CI 1.01; 9.24]). Glycaemic response to hypoglycaemia contributes to overall glycaemic instability in newborns and is influenced by treatment. Slow or rapid recovery of hypoglycaemia appears to be associated with neurosensory impairment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Association between interstitial glucose (IG) parameters in six-hour epochs following neonatal hypoglycaemia and neurosensory impairment in early childhood. Exposure effect is presented as odds of neurosensory impairment by tertile of IG parameter (referent middle tertile). Results adjusted for socio-economic status, gestational age, birth weight Z score and blood glucose concentration at the beginning of the epoch. Triangles denote tertile 1, circles tertile 2 (reference) and squares tertile 3. Tertile values are as follows: hours to reach maximum IG (1: 0.4–2.2; 2: 2.3–4.2; 3: 4.3–6.0), average IG (1: 1.7–2.9; 2: 2.9–3.3; 3: 3.4–6.2 mmol/L), maximum IG (1: 2.6–3.4; 2: 3.5–4.0; 3: 4.1–8.7 mmol/L), minimum IG (1: 0.1–2.1; 2: 2.1–2.3; 3: 2.4–2.8 mmol/L), IG range (1: 0.3–1.2; 2: 1.3–1.9; 3: 2.0–7.0 mmol/L), proportion of IG measurements outside central band of 3–4 mmol/L (1: 0.06–0.39; 2: 0.40–0.68; 3: 0.69–1.00), hours <2.6 mmol/L (1:0.2–0.5; 2: 0.6–1.3; 3: 1.4–5.9).

References

    1. Hawdon JM. Investigation, prevention and management of neonatal hypoglycaemia (impaired postnatal metabolic adaptation) Paediatr Child Health (GBR). 2012;22:131–135. doi: 10.1016/j.paed.2011.08.006. - DOI
    1. Platt MW, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med. 2005;10:341–350. doi: 10.1016/j.siny.2005.04.001. - DOI - PubMed
    1. Swanson JR, Sinkin RA. Transition from fetus to newborn. Pediatr Clin North Am. 2015;62:329–343. doi: 10.1016/j.pcl.2014.11.002. - DOI - PubMed
    1. Hawdon JM. Investigation and management of impaired metabolic adaptation presenting as neonatal hypoglycaemia. Paediatr Child Health (GBR). 2008;8:161–165. doi: 10.1016/j.paed.2007.12.012. - DOI
    1. Hawdon JM. Postnatal metabolic adaptation and neonatal hypoglycaemia. Paediatr Child Health. 2016;26:135–139. doi: 10.1016/j.paed.2015.12.001. - DOI

Publication types

MeSH terms